Feb 25, 2020 (KD Market Insights via COMTEX) -- Antifibrinolytic Drugs Market by Indication (Gynecology, Hereditary Angiedema, Fibrinolytic Response Testing, Surgeries, and Others) and End user (Hospitals & Clinics, Ambulatory Surgical Centers, and Healthcare Specialty Process): Global Opportunity Analysis and Industry Forecast, 2019-2026
The Worldwide Antifibrinolytic Drugs Market is estimated to grow at a CAGR of 4.5% during the forecast period 2019-2026. As per the analysis, the market was valued at $1,3593 million in the year 2018 and is anticipated to reach $1,9333 million by the end of the year 2026.
Antifibrinolytics drug belongs to a class of medication that are inhibitors of fibrinolysis such as tranexamic acid and aminocaproic acid. This drug is use to control or prevent bleeding during or after surgical procedures--increasing number of surgical procedures enhance the usage of antifibrinolytics drug and impact the market growth. Apart from surgical procedures, antifibrinolytics is used to prevent bleeding in some serious diseases such as types of vascular tumors, heavy menstrual bleeding, hemophilia and others.
No comments:
Post a Comment